<div id="readability-page-1"><ul><li>Zoom Video Indicates Normalization Ends and Growth Resumes</li></ul><p>Diageo, UP Fintech, Regencell Bioscience, RBB Bancorp, Universe Pharmaceuticals, Taoping,  and BGM Group are the seven Chinese stocks to watch today, according to MarketBeat's stock screener tool. Chinese stocks are shares of companies domiciled in or primarily operating in China, traded on domestic exchanges (e.g., Shanghai and Shenzhen A‑ and B‑shares), on the Hong Kong exchange (H‑shares and red chips), or abroad via listings and ADRs. For investors, they offer exposure to China’s growth but come with specific risks such as regulatory and political intervention, differing accounting and governance standards, currency fluctuations, and varying liquidity across markets. These companies had the highest dollar trading volume of any Chinese stocks within the last several days.</p><h2>Diageo (DEO)</h2><p>Diageo plc, together with its subsidiaries, engages in the production, marketing, and sale of alcoholic beverages. The company offers scotch, gin, vodka, rum, raki, liqueur, wine, tequila, Chinese white spirits, cachaça, and brandy, as well as beer, including cider and flavored malt beverages. It also provides Chinese, Canadian, Irish, American, and Indian-Made Foreign Liquor whiskies, as well as flavored malt beverages, ready to drink, and non-alcoholic products.</p><ul><li>Modelo Sale Success Propels Constellation Brands In The Market</li></ul><p>Read Our Latest Research Report on DEO</p><h2>UP Fintech (TIGR)</h2><p>UP Fintech Holding Limited provides online brokerage services focusing on Chinese investors. The company has developed a brokerage platform, which allows investor to trade stocks, options, warrants, and other financial instruments that can be accessed through its APP and website. It offers brokerage and value-added services, including investor education, community engagement, and IR platform services.</p><ul><li>3 Beer Stocks to Tap into if You're Ready for Some Football</li></ul><p>Read Our Latest Research Report on TIGR</p><h2>Regencell Bioscience (RGC)</h2><p>Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder.</p><p>Read Our Latest Research Report on RGC</p><h2>RBB Bancorp (RBB)</h2><p>RBB Bancorp operates as the bank holding company for Royal Business Bank that provides various banking products and services to the Chinese-American, Korean-American, and other Asian-American communities. Its deposit products include checking, savings, and money market accounts, as well as certificates of deposit.</p><p>Read Our Latest Research Report on RBB</p><h2>Universe Pharmaceuticals (UPC)</h2><p>Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications.</p><p>Read Our Latest Research Report on UPC</p><h2>Taoping (TAOP)</h2><p>Taoping Inc. provides cloud-based platform, resource sharing, and big data solutions to the Chinese new media, education residential community management, and elevator Internet of Things (IoT) industries in the People's Republic of China. It operates through Cloud-Based Technology and Traditional Information Technology segments.</p><p>Read Our Latest Research Report on TAOP</p><h2>BGM Group (BGM)</h2><p>Qilian International Holding Group Limited manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions.</p><p>Read Our Latest Research Report on BGM</p><h2>Recommended Stories</h2><ul><li>MarketBeat's Top Five Stocks to Own in December 2025</li><li>Kroger Stock Analysis: Digital Pivot, Dividend Safety &amp; 2026 Growth Plan</li><li>Will Crypto Miners Pivot to AI? Latest on 3 Key Players</li><li>Salesforce Stock Is Coiled Like a Spring and Ready to Rebound</li><li>Marvell's Rally Extends: Data Centers and AMZN Chips Boost Shares</li><li>Could Ross Stores Stock Hit $200 by Christmas? Here Are 3 Reasons Analysts Think So</li></ul><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Diageo Right Now?</h2><p>Before you consider Diageo, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Diageo wasn't on the list.</p><p>While Diageo currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

TIGR

<p>MarketBeat's stock screener tool highlights seven Chinese stocks to watch: Diageo, UP Fintech, Regencell Bioscience, RBB Bancorp, Universe Pharmaceuticals, Taoping, and BGM Group. These stocks offer exposure to China's growth but come with risks like regulatory intervention and currency fluctuations. Diageo, despite its Reduce rating, is not among the top five stocks recommended by analysts. The report emphasizes the importance of considering these stocks for potential investment opportunities.</p>

Best Chinese Stocks To Research - December 5th